article thumbnail

Digital Therapeutics Might Address Gaps in Care for Mental Health Patients

Pharmacy Times

Pharmacists should be well educated on prescription digital therapeutics to better educate patients on software in comparison to traditional pharmacological products.

article thumbnail

Chiesi joins with Aptar on digital platform for respiratory patients

pharmaphorum

Hard on the heels of the official launch of its digital disease management platform, Aptar Pharma has secured a partnership with Italian drugmaker Chiesi to deploy it in support of patients. The post Chiesi joins with Aptar on digital platform for respiratory patients appeared first on. billion of its total revenues of €2.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Channels Identified as Possible Pharmacological Targets for Kidney Potassium Handling

Pharmacy Times

Next-generation research shows that targeting specific Kir channels, which regulate salt reabsorption in the kidneys, could improve diuretic function in kidney patients.

article thumbnail

Important Lifestyle Modifications, Non-Pharmacologic Options for Patients with Diabetes

Pharmacy Times

Lifestyle modifications are the cornerstone of treatment.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Legacy MEDSearch

“At Cala, we’ve always been committed to expanding patient access and accelerating innovation in TAPS therapy for indications beyond essential tremor,” said Renee Ryan, CEO at Cala. “By By expanding into Parkinson’s disease, we are now able to bring this powerful treatment to additional patients who suffer from action hand tremors.”

article thumbnail

Clinical Overview: Potentially Harmful Medications in Heart Failure

Pharmacy Times

An average patient with heart failure can take up to 6 medications for guideline-directed medical therapy; however, they may have other comorbidities that require pharmacologic management.

Medical 49